| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.55B | 36.34B | 34.19B | 29.06B | 24.98B | 20.87B |
| Gross Profit | 8.22B | 8.24B | 7.85B | 6.61B | 6.09B | 4.89B |
| EBITDA | 5.28B | 5.14B | 5.05B | 4.22B | 4.10B | 3.33B |
| Net Income | 3.23B | 3.16B | 3.13B | 2.69B | 2.52B | 2.08B |
Balance Sheet | ||||||
| Total Assets | 25.06B | 25.71B | 23.50B | 21.74B | 18.99B | 16.55B |
| Cash, Cash Equivalents and Short-Term Investments | 11.19B | 12.88B | 12.12B | 10.20B | 11.27B | 8.25B |
| Total Debt | 200.00M | 200.00M | 200.00M | 700.00M | 200.00M | 571.45M |
| Total Liabilities | 6.40B | 7.24B | 6.69B | 6.64B | 5.17B | 4.19B |
| Stockholders Equity | 18.66B | 18.47B | 16.80B | 15.10B | 13.82B | 12.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.98B | 3.18B | 1.83B | 4.39B | 1.31B |
| Operating Cash Flow | 0.00 | 3.19B | 3.42B | 1.95B | 4.42B | 1.56B |
| Investing Cash Flow | 0.00 | -923.00M | 449.00M | -1.71B | 31.00M | -1.39B |
| Financing Cash Flow | 0.00 | -1.51B | -1.95B | -1.30B | -1.44B | -813.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥69.67B | 18.88 | 17.96% | 1.83% | 13.23% | 16.07% | |
73 Outperform | ¥46.48B | 18.47 | 17.50% | 2.88% | 5.62% | 3.81% | |
69 Neutral | ¥31.58B | 13.32 | ― | 2.22% | 9.57% | 315.38% | |
68 Neutral | ¥27.72B | 11.13 | ― | 4.36% | 12.32% | 10.42% | |
65 Neutral | ¥31.25B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |